Logotype for National Health Investors Inc

National Health Investors (NHI) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for National Health Investors Inc

Proxy Filing summary

1 Dec, 2025

Executive summary

  • Achieved a return to growth in 2024, with increases in Nareit FFO, Normalized FFO, and Funds Available for Distribution, surpassing initial expectations.

  • Total Shareholder Return (TSR) for 2024 was 30.6%, outperforming the Nareit Healthcare REIT Index and continuing multi-year outperformance.

  • Portfolio optimization led to $11 million in deferral repayments and a 32% increase in Senior Housing Operating Portfolio NOI.

  • Over $235 million invested at an average yield of 8.6%, with leverage improved to a net debt-to-adjusted EBITDA of 4.1x.

  • Raised $262 million in equity, with $119 million remaining available; closed a $67.5 million acquisition in January and have $106 million under LOI.

Voting matters and shareholder proposals

  • Proposal 1: Election of four directors for one-year terms if Proposal 2 passes, or two/three-year terms if not.

  • Proposal 2: Amendment to declassify the Board, moving to annual director elections by 2027.

  • Proposal 3: Advisory vote on executive compensation (say-on-pay).

  • Proposal 4: Ratification of BDO USA, P.C. as independent auditor for 2025.

  • Proposal 5: Stockholder proposal from Land & Buildings (L&B) to declassify the Board, which the Board recommends voting against in favor of Proposal 2.

  • L&B is nominating two dissident directors; the Board recommends voting for its own four nominees.

Board of directors and corporate governance

  • Board expanded from four to eight members since 2020, with female representation rising to 37.5% and average tenure dropping to seven years.

  • Recent retirements of two founding members; five new independent directors added in five years.

  • Special Committee of Non-Interested Directors established to oversee NHC lease negotiations.

  • Board leadership separated between Chair (McCabe) and CEO (Mendelsohn); six of eight directors are independent.

  • Enhanced governance guidelines, including strengthened director qualification standards and stock ownership requirements.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more